Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost–Benefit Analysis of Monoclonal Antibody Cultivation Scenarios in Terms of Life Cycle Environmental Impact and Operating Cost
Eri Amasawa, Hiroaki Kuroda, Kozue Okamura, et al.
ACS Sustainable Chemistry & Engineering (2021) Vol. 9, Iss. 42, pp. 14012-14021
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

HealthcareLCA: an open-access living database of health-care environmental impact assessments
Jonathan Drew, Sean Christie, Daniel Rainham, et al.
The Lancet Planetary Health (2022) Vol. 6, Iss. 12, pp. e1000-e1012
Open Access | Times Cited: 52
Killer to cure: Expression and production costs calculation of tobacco plant‐made cancer‐immune checkpoint inhibitors
Laura A. Ridgley, Nicole Falci Finardi, Benjamin Bruno Gengenbach, et al.
Plant Biotechnology Journal (2023) Vol. 21, Iss. 6, pp. 1254-1269
Open Access | Times Cited: 20
Can biotechnology lead the way toward a sustainable pharmaceutical industry?
Deniz Etit, Samir Meramo, Ólafur Ögmundarson, et al.
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103100-103100
Open Access | Times Cited: 8
Challenges and opportunities for computer-aided molecular and process design approaches in advancing sustainable pharmaceutical manufacturing
Claire S. Adjiman, Amparo Galindo
Current Opinion in Chemical Engineering (2025) Vol. 47, pp. 101073-101073
Open Access
Life Cycle Assessment of Active Pharmaceutical Ingredient Production: A case study of Citicoline
Ryuji Kaji, Takashi Shimizu, Yasunori Kikuchi, et al.
Process Safety and Environmental Protection (2025), pp. 106836-106836
Closed Access
Recent development of microfluidic biosensors for the analysis of antibiotic residues
Xiaorui Wang, Yaoshuang Xie, Ling Lin
TrAC Trends in Analytical Chemistry (2022) Vol. 157, pp. 116797-116797
Closed Access | Times Cited: 27
A model-based performance analysis of integrated chromatography-ultrafilter separation systems for monoclonal antibody (mAb) manufacturing
Wil Jones, Dimitrios I. Gerogiorgis
Biochemical Engineering Journal (2024) Vol. 206, pp. 109281-109281
Open Access | Times Cited: 4
Digital models in biotechnology: Towards multi-scale integration and implementation
Fabian Stefan Franz Hartmann, Isuru A. Udugama, Gerd M. Seibold, et al.
Biotechnology Advances (2022) Vol. 60, pp. 108015-108015
Open Access | Times Cited: 22
Status and future developments for downstream processing of biological products
Alois Jungbauer, Gisela Ferreira, Michelle Butler, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 8, pp. 2524-2541
Open Access | Times Cited: 3
Reviewing the process intensification landscape through the introduction of a novel, multitiered classification for downstream processing
Louis Crowley, Paul Cashen, Marc Noverraz, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 3, pp. 877-893
Open Access | Times Cited: 2
Sustainability in Healthcare: Methods and Tools for the Assessment
Anna Savoldelli, Daniele Landi, Caterina Rizzi
Studies in health technology and informatics (2023)
Open Access | Times Cited: 7
Customer-centric product presentations for monoclonal antibodies
Beate Bittner
AAPS Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Early-stage economic and environmental impact assessment for optimized bioprocess development: Monoterpenoid indole alkaloids
Deniz Etit, Ólafur Ögmundarson, Jie Zhang, et al.
Bioresource Technology (2023) Vol. 391, pp. 130005-130005
Open Access | Times Cited: 5
Promises and challenges of single-domain antibodies to control influenza
Arne Matthys, Xavier Saelens
Antiviral Research (2024) Vol. 222, pp. 105807-105807
Closed Access | Times Cited: 1
Valorisation of Spent Yeast Fermentation Media through Compositional-Analysis-Directed Supplementation
Laura Murphy, Ciara D. Lynch, David O’Connell
Applied Microbiology (2024) Vol. 4, Iss. 2, pp. 959-971
Open Access | Times Cited: 1
Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments
Tomás Gabriel Bas, Vannessa Duarte
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 925-925
Open Access | Times Cited: 1
Dynamic simulation, optimisation and economic analysis of fed-batch vs. perfusion bioreactors for advanced mAb manufacturing
Wil Jones, Dimitrios I. Gerogiorgis
Computers & Chemical Engineering (2022) Vol. 165, pp. 107855-107855
Open Access | Times Cited: 9
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
Sarfaraz K. Niazi
ClinicoEconomics and Outcomes Research (2023) Vol. Volume 15, pp. 281-294
Open Access | Times Cited: 4
Continuous cold ethanol precipitation of immunoglobulin G from human plasma
Nico Lingg, Markus Mozgovicz, Theresa Schaufler, et al.
Process Biochemistry (2023) Vol. 132, pp. 121-129
Open Access | Times Cited: 2
Qualification of a LC-HRMS platform method for biosimilar development using NISTmab as a model
Paresh Tank, Shruti Vora, Sarita Tripathi, et al.
Analytical Biochemistry (2024) Vol. 688, pp. 115475-115475
Open Access
Feeding secondary fermentations with mammalian and fungal culture waste streams increases productivity and resource efficiency
Ciara D. Lynch, Federico Cerrone, Kevin E. O’Connor, et al.
RSC Sustainability (2024) Vol. 2, Iss. 6, pp. 1868-1882
Open Access
A High-Avidity, Thermostable, and Low-Cost Synthetic Capture for Ultrasensitive Detection and Quantification of Viral Antigens and Aerosols
Sean Wang, Rohit Gupta, Ananya Benegal, et al.
ACS Sensors (2024) Vol. 9, Iss. 6, pp. 3096-3104
Closed Access
Economic analysis of buffer preparation strategy for single-use bioprocessing of monoclonal antibodies
Takao Ito, Ann-Kathrin Uebele, Takashi Nihei, et al.
EFB Bioeconomy Journal (2024) Vol. 4, pp. 100065-100065
Open Access
Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis
Ruben Malmberg, Jurrien H Loosveld, Hans-Peter Schilte, et al.
The Lancet Planetary Health (2024) Vol. 8, Iss. 11, pp. e915-e923
Closed Access
In silico design and discovery of pan coronavirus small molecule anti-virals targeting 3CL PRO protease
Satish Kumar Manjhi, Aman Achuthan Kattuparambil, Bibhudutta Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access
Page 1 - Next Page

Scroll to top